48
Views
12
CrossRef citations to date
0
Altmetric
Research Paper

Retinal tissue thickness in type 1 and type 2 diabetes

, PhD, , PhD FAAO, , PhD, , PhD, , PhD, , PhD MBBS, , PhD MBChB FRCP & , AC PhD DSc show all
Pages 78-83 | Received 19 Feb 2015, Accepted 26 Apr 2015, Published online: 15 Apr 2021

References

  • Wild S, Roglic G, Green A, Sicree R, King H. Global prevalence of diabetes: Estimates for the year 2000 and projections for 2030. Diabetes Care 2004; 27: 1047–1053.
  • Zimmet PZ, Shaten BJ, Kuller LH, Rowley MJ, Knowles WJ, Mackay IR, Group MR. Antibodies to glutamic acid decarboxylase and diabetes mellitus in the multiple risk factor intervention trial. Am J Epidemiol 1994; 140: 683–690.
  • Neilson NV, Vinding T. The prevalence of cataracts in insulin‐dependent and non‐insulin‐dependent diabetes mellitus. An epidemiological study of diabetics treated with insulin and oral hypoglycaemic agents (OHA). Acta Ophthalmol 1984; 62: 595–602.
  • Caird FI, Pirie A, Ramsell TG. Diabetes and the Eye. Oxford, UK: Blackwell Scientific, 1969.
  • Bronson‐castain KW, Bearse MA, Neuville J, Jonasdottir S, King‐hooper B, Barez S, et al. Adolescents with type 2 diabetes: Early indications of focal retinal neuropathy, retinal thinning and venular dilation. Retina 2009; 29: 618–626.
  • Oshitari T, Hanawa K, Adachi‐usami E. Changes of macular and RNFL thicknesses measured by stratus OCT in patients with early stage diabetes. Eye 2009; 23: 884–889.
  • Eriksson U, Alm A. Macular thickness decreases with age in normal eyes: A study on the macular thickness map protocol in the stratus OCT. Br J Ophthalmol 2009; 93: 1448–1452.
  • Alamouti B, Funk, J. Retinal thickness decreases with age: An OCT study. Br J Ophthalmol 2003; 87; 899–901.
  • Fraser‐bell S, Varma R, Lipyanik J, Patella VM, Budenz D, Cantor L. Age, gender, ethnicity and refractive error related differences in normal macular thickness and volume as measured by Stratus OCT. Invest Ophthalmol Vis Sci 2005; 46: E‐Abstract1542.
  • Kashani AH, Zimmer‐galler IE, Shah SM, Dustin L, Do DV, Eliott D, et al. Retinal thickness analysis by race, gender, and age using Stratus OCT. Am J Ophthalmol 2010; 149: 496–502.
  • Bressler NM, Edwards AR, Antoszyk AN, Beck RW, Browning DJ, Ciardella AP, et al. Retinal thickness on Stratus optical coherence tomography in people with diabetes and minimal or no diabetic retinopathy. Am J Ophthalmol 2008; 145: 894–901.
  • Budenz DL, Anderson DR, Varma R, Schuman J, Cantor L, Savell J, et al. Determinants of normal retinal nerve fiber layer thickness measured by Stratus OCT. Ophthalmology 2007; 114: 1046–1052.
  • Koh VT, Tham Y‐C, Cheung CY, Wong W‐L, Baskaran M, Saw S‐M, et al. Determinants of ganglion cell–inner plexiform layer thickness measured by high‐definition optical coherence tomography. Invest Ophthalmol Vis Sci 2012; 53: 5853–5859.
  • van Dijk HW, Kok PH, Garvin M, Sonka M, Devries JH, Michels RP. Selective loss of inner retinal layer thickness in type 1 diabetic patients with minimal diabetic retinopathy. Invest Ophthalmol Vis Sci 2009; 50: 3404–3409.
  • van Dijk HW, Verbraak FD, Kok PH, Garvin MK, Sonka M, Lee K, et al. Decreased retinal ganglion cell layer thickness in patients with type 1 diabetes. Invest Ophthalmol Vis Sci 2010; 51: 3660–3665.
  • Nilsson M, Von wendt G, Wanger P, Martin L. Early detection of macular changes in patients with diabetes using rarebit fovea test and optical coherence tomography. Br J Ophthalmol 2007; 91: 1596–1598.
  • Asefzadeh B, Fisch BM, Parenteau CE, Cavallerano AA. Macular thickness and systemic markers for diabetes in individuals with no or mild diabetic retinopathy. Clin Experiment Ophthalmol 2008; 36: 455–463.
  • Hajee ME, March WF, Lazzaro DR, Wolintz AH, Shrier EM, Glazman S, Bodis‐wollner IG. Inner retinal layer thinning in Parkinson disease. Arch Ophthalmol 2009; 127: 737–741.
  • Kerrison JB, Flynn T, Green WR. Retinal pathologic changes in multiple sclerosis. Retina 1994; 14: 445–451.
  • Davis MD, Fisher MR, Gangnon RE, Barton F, Aiello LM, Chew EY, et al. Risk factors for high‐risk proliferative diabetic retinopathy and severe visual loss: Early Treatment Diabetic Retinopathy Study report #18. Invest Ophthalmol Vis Sci 1998; 39: 233–252.
  • Fong DS, Aiello L, Gardner TW, King GL, Blankenship G, Cavallerano JD, et al. Retinopathy in diabetes. Diabetes Care 2004; 27: s84–s87.
  • Photocoagulation for diabetic macular edema. Early Treatment Diabetic Retinopathy Study report number 1. Early Treatment Diabetic Retinopathy Study research group. Arch Ophthalmol 1985; 103: 1796–1806.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.